Antimicrobial Resistance Diagnostics Global Market Report 2026
상품코드:1939233
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
항균제 내성 진단 시장의 규모는 최근 현저하게 확대하고 있습니다. 2025년 44억 1,000만 달러에서 2026년에는 47억 4,000만 달러로, CAGR 7.5%로 성장이 전망되고 있습니다. 지난 수년간의 성장세는 항생제 내성 감염 증가, 기존 배양 기반 진단에 대한 의존도 증가, 병원내 감염 증가, 항균제 적정 사용에 대한 인식 증가, 임상미생물 검사실 확대 등이 원인으로 추정됩니다.
항균제 내성 진단 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 62억 3,000만 달러에 달하며, CAGR은 7.1%에 달할 전망입니다. 예측 기간 중의 성장 요인으로는 PCR 및 차세대 염기서열 분석(NGS) 진단 기술의 발전, AMR 모니터링 프로그램에 대한 정부 자금 지원 증가, 신속 진단 검사의 보급 확대, 제약 및 생명공학 연구의 성장, 데이터베이스 의사결정 지원 툴의 통합 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 신속한 현장진단형 AMR 진단의 도입 확대, 표적 맞춤형 항균요법에 대한 수요 증가, 약제 내성 병원체 감시 강화, 분자 및 유전체 기반 진단 검사 확대, 병원 감염 관리 및 약물 관리 프로그램 강화 등이 있습니다.
약제 내성 감염증의 발생률 증가는 향후 수년간 항균제 내성 진단 시장의 성장을 촉진할 것으로 예측됩니다. 이러한 감염은 박테리아, 바이러스, 곰팡이 또는 기생충이 기존에 효과적이었던 약물에 저항할 수 있는 메커니즘을 개발함으로써 발생하며, 표준 치료의 효과를 떨어뜨리고 감염을 통제하기 어렵게 만듭니다. 약제 내성 감염 증가는 주로 농업 분야에서 항생제 과다 사용과 관련이 있습니다. 저용량의 항균제가 가축 사료에 일상적으로 첨가되어 내성을 촉진하고, 먹이사슬을 통해 인간에게 확산될 수 있습니다. 신속 유전자 검사 및 배양 기반 감수성 테스트와 같은 항균제 내성 진단은 내성 병원체를 조기에 발견하고, 표적 치료를 유도하고, 광범위 항생제의 오남용을 줄임으로써 이 문제를 해결하는 데 중요한 역할을 할 수 있습니다. 예를 들어 2024년 11월 영국보건안전청(UKHSA)이 보고한 바에 따르면 영국내 심각한 항생제 내성 감염은 2022년 5만 8,224건에서 2023년 6만 6,730건으로 증가할 것으로 예상했습니다. 한편, 같은 기간 항생제 사용량은 2.4% 증가하여 약제 내성 감염의 확산이 항균제 내성 진단 시장의 확대를 주도하고 있는 현실을 확인할 수 있었습니다.
항균제 내성(AMR) 진단 시장에서 사업을 운영하는 주요 기업은 진단 속도, 정확도, 항균제 적정 사용 성과 향상을 위해 Point-of-Care 항균제 감수성 검사(AST) 솔루션 등 첨단 기술 활용을 중시하고 있습니다. 현장 항균제 감수성 검사(AST)는 감염에 효과적인 항생제를 신속하게 확인할 수 있는 환자 근거리 검사로, 임상의가 표적 치료제를 신속하게 선택할 수 있도록 도와줍니다. 예를 들어 2023년 6월 일본의 체외진단 솔루션 프로바이더인 시스멕스(Sysmex Corporation)는 소변 검체내 세균의 존재를 감지하고 약 30분 만에 항균제 감수성을 판단할 수 있는 Point-of-Care 신속 AST 플랫폼 'PA-100 AST 시스템'을 도입했습니다. 본 시스템은 마이크로플루이딕스 단일 세포 분석, 환자와 가까운 곳에서 검사 기능, 민감도 결과 자동 보고 기능을 내장하고 있습니다. PA-100 AST 시스템은 임상적 판단의 정확성 향상, 불필요한 항생제 사용 최소화, 항균제 내성 대책으로 적시에 표적화된 치료 촉진에 기여합니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 용도 산업의 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장의 세계 TAM(Total Addressable Market)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 대기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 합병과 인수
제40장 시장의 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSA
영문 목차
영문목차
Antimicrobial resistance (AMR) diagnostics are tests designed to detect microorganisms that have developed resistance to antibiotics or other antimicrobial agents. These diagnostics identify the specific pathogen and determine its resistance or susceptibility to various drugs, enabling targeted and effective treatment. AMR diagnostics play a crucial role in controlling the spread of resistant infections and guiding appropriate antimicrobial use in both clinical and public health settings.
The primary product types in the antimicrobial resistance diagnostics market include kits and reagents, instruments, and consumables. Kits and reagents consist of standardized chemicals and biological materials used to detect or measure specific pathogens or substances in diagnostic tests. These diagnostics target various pathogens such as drug-resistant Streptococcus pneumoniae (DRSP), drug-resistant Campylobacter (DRC), Clostridium difficile (CD), methicillin-resistant Staphylococcus aureus (MRSA), drug-resistant Neisseria gonorrhoeae (DRNG), drug-resistant Salmonella (DRNTS), and other resistant organisms. A variety of technologies are employed, including microbiology culture, immunoassay, polymerase chain reaction (PCR), next-generation sequencing (NGS), mass spectrometry, rapid and point-of-care testing, and others. Key end users include hospitals and clinics, diagnostic laboratories, research institutes, pharmaceutical and biotechnology companies, among others.
Tariffs are impacting the antimicrobial resistance diagnostics market by increasing the cost of imported instruments, reagents, and advanced molecular testing equipment such as pcr and ngs systems. Kits and reagents along with high-end diagnostic instruments are most affected, particularly in asia-pacific and emerging markets that depend heavily on imported technologies. These cost pressures can slow adoption in smaller laboratories and healthcare facilities. However, tariffs are also encouraging local manufacturing, regional sourcing of consumables, and investments in domestic diagnostic production capabilities, supporting long-term market sustainability.
The antimicrobial resistance diagnostics market research report is one of a series of new reports from The Business Research Company that provides antimicrobial resistance diagnostics market statistics, including antimicrobial resistance diagnostics industry global market size, regional shares, competitors with a antimicrobial resistance diagnostics market share, detailed antimicrobial resistance diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the antimicrobial resistance diagnostics industry. This antimicrobial resistance diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The antimicrobial resistance diagnostics market size has grown strongly in recent years. It will grow from $4.41 billion in 2025 to $4.74 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing prevalence of antibiotic-resistant infections, reliance on conventional culture-based diagnostics, rising hospital-acquired infections, growing awareness of antimicrobial stewardship, expansion of clinical microbiology laboratories.
The antimicrobial resistance diagnostics market size is expected to see strong growth in the next few years. It will grow to $6.23 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to advancement in pcr and ngs diagnostic technologies, increasing government funding for amr surveillance programs, rising adoption of rapid diagnostic tests, growth in pharmaceutical and biotechnology research, integration of data-driven decision support tools. Major trends in the forecast period include rising adoption of rapid and point-of-care amr diagnostics, growing demand for targeted and personalized antimicrobial therapy, increased surveillance of drug-resistant pathogens, expansion of molecular and genomic-based diagnostic testing, strengthening of hospital infection control and stewardship programs.
The increasing incidence of drug-resistant infections is expected to drive the growth of the antimicrobial resistance diagnostics market in the coming years. These infections occur when bacteria, viruses, fungi, or parasites develop mechanisms to survive medications that were previously effective, making standard treatments less effective and infections harder to control. The rise in drug-resistant infections is largely linked to the overuse of antibiotics in agriculture, where low-dose antimicrobials are routinely added to animal feed, promoting resistance that can spread to humans through the food chain. Antimicrobial resistance diagnostics, such as rapid genetic assays and culture-based sensitivity tests, play a key role in addressing this challenge by enabling early detection of resistant pathogens, guiding targeted therapies, and reducing the misuse of broad-spectrum antibiotics. For instance, in November 2024, the UK Health Security Agency (UKHSA) reported that serious antibiotic-resistant infections in England increased from 58,224 in 2022 to an estimated 66,730 in 2023, while antibiotic usage rose to 2.4% over the same period, highlighting how the growing prevalence of drug-resistant infections is driving the expansion of the antimicrobial resistance diagnostics market.
Major companies operating in the antimicrobial resistance (AMR) diagnostics market are emphasizing the use of advanced technologies such as point-of-care antimicrobial-susceptibility testing (AST) solutions to improve diagnostic speed, accuracy, and antimicrobial stewardship outcomes. Point-of-care antimicrobial-susceptibility testing (AST) involves rapid, near-patient testing that identifies which antibiotics are effective against an infection, enabling clinicians to promptly select targeted treatments. For example, in June 2023, Sysmex Corporation, a Japan-based provider of in-vitro diagnostic solutions, introduced the PA-100 AST System, a point-of-care rapid AST platform capable of detecting bacterial presence and determining antimicrobial susceptibility in urine samples in about 30 minutes. The system incorporates microfluidic single-cell analysis, near-patient testing functionality, and automated reporting of susceptibility results. The PA-100 AST System enhances clinical decision-making, minimizes unnecessary antibiotic use, and facilitates timely, targeted therapy to address antimicrobial resistance.
In June 2025, bioMerieux, a France-based provider of in vitro diagnostic (IVD) solutions and infectious disease testing technologies, acquired the assets of Day Zero Diagnostics for an undisclosed amount. Through this acquisition, bioMerieux obtains access to Day Zero Diagnostics' next-generation sequencing (NGS) workflows, NGS chemistries, bioinformatics pipeline, and AI-driven antimicrobial resistance (AMR) prediction technologies, thereby enhancing its next-generation antimicrobial resistance diagnostics capabilities and strengthening its innovation pipeline in rapid pathogen identification and antimicrobial susceptibility testing (AST). Day Zero Diagnostics is a US-based developer of sequencing-based infectious disease diagnostic technologies.
Major companies operating in the antimicrobial resistance diagnostics market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Becton Dickinson And Company, bioMerieux SA, Sysmex Corporation, Bio Rad Laboratories Inc, QIAGEN NV, Seegene Inc, Alifax S r l, Accelerate Diagnostics Inc, Molsid SAS, Genetic Signatures Limited, iFAST Diagnostics Ltd, Astek Diagnostics Inc, OpGen Inc, T2 Biosystems, Jiangsu Medomics Medical Technology Co Ltd, Cepheid, Luminex Corporation, Bruker Corporation, Hologic Inc
North America was the largest region in the antimicrobial resistance diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antimicrobial resistance diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the antimicrobial resistance diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The antimicrobial resistance diagnostics market consists of revenues earned by entities by providing services such as pathogen identification, resistance gene detection, rapid screening, antimicrobial susceptibility testing, and diagnostic data interpretation. The market value includes the value of related goods sold by the service provider or included within the service offering. The antimicrobial resistance diagnostics market includes sales of polymerase chain reaction (PCR) instruments, immunoassay kits, point-of-care testing devices, sequencing reagents, and microbiology culture consumables. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Antimicrobial Resistance Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses antimicrobial resistance diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for antimicrobial resistance diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The antimicrobial resistance diagnostics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Product Type: Kits And Reagents; Instruments And Consumables
2) By Pathogen: Drug-Resistant Streptococcus Pneumoniae (DRSP); Drug Resistant Campylobacter (DRC); Clostridium Difficile (CD); Methicillin Resistant Staphylococcus Aureus (MRSA); Drug Resistant Neisseria Gonorrhoeae (DRNG); Drug Resistant Salmonella (DRntS); Other Pathogens
3) By Technology: Microbiology Culture; Immunoassay; PCR (Polymerase Chain Reaction); NGS (Next-Generation Sequencing); Mass Spectrometry; Rapid And Point Of Care; Other Technologies
4) By End-User: Hospitals And Clinics; Diagnostics Laboratories; Research Institutes; Pharmaceutical And Biotechnology Companies; Other End Users
Subsegments:
1) By Kits And Reagents: Deoxyribonucleic Acid (DNA) Extraction Kits; Ribonucleic Acid (RNA) Extraction Kits; Polymerase Chain Reaction (PCR) Reagents; Immunoassay Reagents; Stains And Dyes; Culture Media
2) By Instruments And Consumables: Polymerase Chain Reaction (PCR) Machines; Ultraviolet-Visible (UV-Vis) Spectrophotometers; Next-Generation Sequencing (NGS) Systems; Microarray Scanners; Automated Liquid Handlers; Sample Collection Tubes And Swabs
Companies Mentioned: F Hoffmann La Roche AG; Thermo Fisher Scientific Inc; Abbott Laboratories; Danaher Corporation; Becton Dickinson And Company; bioMerieux SA; Sysmex Corporation; Bio Rad Laboratories Inc; QIAGEN NV; Seegene Inc; Alifax S r l; Accelerate Diagnostics Inc; Molsid SAS; Genetic Signatures Limited; iFAST Diagnostics Ltd; Astek Diagnostics Inc; OpGen Inc; T2 Biosystems; Jiangsu Medomics Medical Technology Co Ltd; Cepheid; Luminex Corporation; Bruker Corporation; Hologic Inc
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.2 Biotechnology, Genomics & Precision Medicine
4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
4.1.4 Industry 4.0 & Intelligent Manufacturing
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Rising Adoption Of Rapid And Point-Of-Care Amr Diagnostics
4.2.2 Growing Demand For Targeted And Personalized Antimicrobial Therapy
4.2.3 Increased Surveillance Of Drug-Resistant Pathogens
4.2.4 Expansion Of Molecular And Genomic-Based Diagnostic Testing
4.2.5 Strengthening Of Hospital Infection Control And Stewardship Programs
5. Antimicrobial Resistance Diagnostics Market Analysis Of End Use Industries
5.1 Hospitals And Clinics
5.2 Diagnostics Laboratories
5.3 Research Institutes
5.4 Pharmaceutical And Biotechnology Companies
5.5 Public Health And Surveillance Agencies
6. Antimicrobial Resistance Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Antimicrobial Resistance Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Antimicrobial Resistance Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Antimicrobial Resistance Diagnostics Market Size, Comparisons And Growth Rate Analysis
7.3. Global Antimicrobial Resistance Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Antimicrobial Resistance Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Antimicrobial Resistance Diagnostics Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9.1. Global Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Kits And Reagents, Instruments And Consumables
9.2. Global Antimicrobial Resistance Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Drug-Resistant Streptococcus Pneumoniae (DRSP), Drug Resistant Campylobacter (DRC), Clostridium Difficile (CD), Methicillin Resistant Staphylococcus Aureus (MRSA), Drug Resistant Neisseria Gonorrhoeae (DRNG), Drug Resistant Salmonella (DRntS), Other Pathogens
9.3. Global Antimicrobial Resistance Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Microbiology Culture, Immunoassay, PCR (Polymerase Chain Reaction), NGS (Next-Generation Sequencing), Mass Spectrometry, Rapid And Point Of Care, Other Technologies
9.4. Global Antimicrobial Resistance Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals And Clinics, Diagnostics Laboratories, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users
9.5. Global Antimicrobial Resistance Diagnostics Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.6. Global Antimicrobial Resistance Diagnostics Market, Sub-Segmentation Of Instruments And Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Antimicrobial Resistance Diagnostics Market
12.1. China Antimicrobial Resistance Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Antimicrobial Resistance Diagnostics Market
13.1. India Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Antimicrobial Resistance Diagnostics Market
14.1. Japan Antimicrobial Resistance Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Antimicrobial Resistance Diagnostics Market
15.1. Australia Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Antimicrobial Resistance Diagnostics Market
16.1. Indonesia Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Antimicrobial Resistance Diagnostics Market
17.1. South Korea Antimicrobial Resistance Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Antimicrobial Resistance Diagnostics Market
19.1. South East Asia Antimicrobial Resistance Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Antimicrobial Resistance Diagnostics Market
20.1. Western Europe Antimicrobial Resistance Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Antimicrobial Resistance Diagnostics Market
21.1. UK Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22.1. Germany Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Antimicrobial Resistance Diagnostics Market
23.1. France Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25.1. Spain Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Antimicrobial Resistance Diagnostics Market
26.1. Eastern Europe Antimicrobial Resistance Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Antimicrobial Resistance Diagnostics Market
27.1. Russia Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Antimicrobial Resistance Diagnostics Market
28.1. North America Antimicrobial Resistance Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Antimicrobial Resistance Diagnostics Market
29.1. USA Antimicrobial Resistance Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Antimicrobial Resistance Diagnostics Market
31.1. South America Antimicrobial Resistance Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Antimicrobial Resistance Diagnostics Market
32.1. Brazil Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Antimicrobial Resistance Diagnostics Market
33.1. Middle East Antimicrobial Resistance Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Antimicrobial Resistance Diagnostics Market
34.1. Africa Antimicrobial Resistance Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Antimicrobial Resistance Diagnostics Market, Segmentation By Product Type, Segmentation By Pathogen, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Antimicrobial Resistance Diagnostics Market Regulatory and Investment Landscape
36. Antimicrobial Resistance Diagnostics Market Competitive Landscape And Company Profiles
